Commercial sensitivity or patient protection? Secrecy and medicine safety

Press/Media: Expert Comment

Description

Researchers have identified an information gap between pharmacological companies and Australian clinicians on the potential safety risks of medicines.

Subject

Medication safety alerts from post-marketing surveillance varies from country to country. There is a failure to make these alerts public and there is a failure of governance at a national level.

Period8 Mar 2019

Media contributions

1

Media contributions

  • TitleCommercial sensitivity or patient protection? Secrecy and medicine safety
    Degree of recognitionNational
    Media name/outletNewsGP
    Media typeWeb
    CountryAustralia
    Date8/03/19
    DescriptionResearchers have identified an information gap between pharmacological companies and Australian clinicians on the potential safety risks of medicines.
    Producer/AuthorAmanda Lyons, RACGP
    PersonsMark Morgan